Massachusetts Financial Services’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-30,396
| Closed | -$159K | – | 888 |
|
|
2023
Q4 | $159K | Sell |
30,396
-960
| -3% | -$5.02K | ﹤0.01% | 828 |
|
|
2023
Q3 | $494K | Sell |
31,356
-1,203
| -4% | -$19K | ﹤0.01% | 803 |
|
|
2023
Q2 | $633K | Sell |
32,559
-767
| -2% | -$14.9K | ﹤0.01% | 776 |
|
|
2023
Q1 | $945K | Buy |
33,326
+14,005
| +72% | +$397K | ﹤0.01% | 765 |
|
|
2022
Q4 | $565K | Buy |
19,321
+407
| +2% | +$11.9K | ﹤0.01% | 813 |
|
|
2022
Q3 | $500K | Buy |
18,914
+5,065
| +37% | +$134K | ﹤0.01% | 815 |
|
|
2022
Q2 | $615K | Buy |
+13,849
| New | +$615K | ﹤0.01% | 800 |
|